Fatimatuzzahra’ Abd Aziz

Dr. Fatimatuzzahra’ Abd Aziz


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Cureus
Verified
Journal Article
Open access
AMAhmed A Mohamed
Ahmed A Mohamed
SASufyan M Alomair
Sufyan M Alomair
AAAbdulrahman A Alnijadi
Abdulrahman A Alnijadi
FAFatimatuzzahra’ Abd Aziz
Fatimatuzzahra’ Abd Aziz
AAAbdulaziz S Almulhim
Abdulaziz S Almulhim
PEPromise M Emeka
Promise M Emeka
Background: Mental illness is a disorder that can cause impairment and disability, affecting mood, thinking, and behavior; therefore, early intervention will reduce morbidity. This study aims to evaluate all the personal, family, societal, and medical barriers that prevent mental health patients from seeking consultation and treatment.

Verified
Journal Article
Open access
PDF file
MAMohammed Ahmed Akkaif
Mohammed Ahmed Akkaif
ABAhmad Bitar
Ahmad Bitar
Laith A.I.K. Al-KaifLaith A.I.K. Al-Kaif
Laith A.I.K. Al-Kaif
NDNur Aizati Athirah Daud
Nur Aizati Athirah Daud
Abubakar Sha'abanAbubakar Sha'aban
Abubakar Sha'aban
BIBaharudin Ibrahim
Baharudin Ibrahim
The global evolution of the SARS-CoV-2 virus is known to all. The diagnosis of SARS-CoV-2 pneumonia is expected to worsen, and mortality will be higher when combined with myocardial injury (MI). The combination of novel coronavirus infections in patients with MI can cause confusion in diagnosis and assessment, with each condition exacerbating the other, and increasing the complexity and difficulty of treatment. It would be a formidable challenge for clinical practice to deal with this situation. Therefore, this review aims to gather literature on the progress in managing MI related to SARS-CoV-2 pneumonia. This article reviews the definition, pathogenesis, clinical evaluation, management, and treatment plan for MI related to SARS-CoV-2 pneumonia based on the most recent literature, diagnosis, and treatment trial reports. Many studies have shown that early diagnosis and implementation of targeted treatment measures according to the different stages of disease can reduce the mortality rate among patients with MI related to SARS-CoV-2 pneumonia. The reviewed studies show that multiple strategies have been adopted for the management of MI related to COVID-19. Clinicians should closely monitor SARS-CoV-2 pneumonia patients with MI, as their condition can rapidly deteriorate and progress to heart failure, acute myocardial infarction, and/or cardiogenic shock. In addition, appropriate measures need to be implemented in the diagnosis and treatment to provide reasonable care to the patient.

25 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Abubakar Sha'abanAbubakar Sha'aban
Abubakar Sha'aban
HZHadzliana Zainal
Hadzliana Zainal
NKNor Azlina Khalil
Nor Azlina Khalil
FAFatimatuzzahra’ Abd Aziz
Fatimatuzzahra’ Abd Aziz
ECEwe Seng Ch'ng
Ewe Seng Ch'ng
BIBaharudin Ibrahim
Baharudin Ibrahim
Background: Low-dose aspirin (LDA) is the backbone for secondary prevention of coronary artery disease, although limited by gastric toxicity. This study aimed to identify novel metabolites that could predict LDA-induced gastric toxicity using pharmacometabolomics. Methods: Pre-dosed urine samples were collected from male Sprague-Dawley rats. The rats were treated with either LDA (10 mg/kg) or 1% methylcellulose (10 mL/kg) per oral for 28 days. The rats’ stomachs were examined for gastric toxicity using a stereomicroscope. The urine samples were analyzed using a proton nuclear magnetic resonance spectroscopy. Metabolites were systematically identified by exploring established databases and multivariate analyses to determine the spectral pattern of metabolites related to LDA-induced gastric toxicity. Results: Treatment with LDA resulted in gastric toxicity in 20/32 rats (62.5%). The orthogonal projections to latent structures discriminant analysis (OPLS-DA) model displayed a goodness-of-fit (R2Y) value of 0.947, suggesting near-perfect reproducibility and a goodness-of-prediction (Q2Y) of −0.185 with perfect sensitivity, specificity and accuracy (100%). Furthermore, the area under the receiver operating characteristic (AUROC) displayed was 1. The final OPLS-DA model had an R2Y value of 0.726 and Q2Y of 0.142 with sensitivity (100%), specificity (95.0%) and accuracy (96.9%). Citrate, hippurate, methylamine, trimethylamine N-oxide and alpha-keto-glutarate were identified as the possible metabolites implicated in the LDA-induced gastric toxicity. Conclusion: The study identified metabolic signatures that correlated with the development of a low-dose Aspirin-induced gastric toxicity in rats. This pharmacometabolomic approach could further be validated to predict LDA-induced gastric toxicity in patients with coronary artery disease.

24 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
AMAhmed Adel Mohamed
Ahmed Adel Mohamed
Abdulaziz AlmulhimAbdulaziz Almulhim
Abdulaziz Almulhim
AAAbdulrahman Alnijadi
Abdulrahman Alnijadi
FAFatimatuzzahra’ Abd Aziz
Fatimatuzzahra’ Abd Aziz
AAAlajmi Alajmi
Alajmi Alajmi
MAMohammad Almutairi
Mohammad Almutairi
Inappropriate prescription patterns and polypharmacy are critical challenges facing the optimal management of schizophrenia patients, especially in regard to patient safety. Background/Objectives: The purpose of this study was to examine the relationship between patient safety and the existence of incorrect prescription patterns and/or polypharmacy in the medications prescribed to individuals with schizophrenia. This issue is addressed in a broad context, highlighting the purpose of this study. Methods: A cross-sectional study was adopted, involving a prospective analysis of the prescriptions of schizophrenia patients receiving treatment. Prescription patterns deemed inappropriate were evaluated based on evidence-based guidelines. Antipsychotic maximum allowable daily doses were calculated using the British National Formulary Maximum Daily Dose (BNFmax), an online tool. Patient safety outcomes were assessed using the Glasgow Antipsychotic Side-effect Scale (GASS). Results: A total of 198 patients diagnosed with schizophrenia and receiving treatment consented to participate in the GASS survey. A total of 116 (58.6%) males participated. The mean age of patients was 40.1 (±12.7). Thirty-one (66.2%) reported mild side effects, while 67 (33.8%) reported moderate side effects. Polypharmacy was detected in 103 (52%) patients’ prescriptions. The correlation between GASS and BNFmax was positive and statistically significant (p < 0.001). The elevation in GASS score was associated with polypharmacy prescriptions (OR 3.21; 95% CI 1.64–6.29), the presence of first-generation antipsychotics (FGAP) (OR 2.79; 95% CI 0.236–5.951), any combination of antipsychotics containing haloperidol (OR 3.22; 95% CI 1.11–9.32), and olanzapine (OR 3.46; 95% CI 1.36–8.79). Conclusions: The safety of patients with schizophrenia has been proven to be impacted by the improper use of psychotropic drugs. Following evidence-based guidelines is a cornerstone to ensuring optimal, effective, and safe patient treatment plans.

13 February 2025 in Health Science Reports
Verified
Journal Article
Open access
Mustapha MohammedMustapha Mohammed
Mustapha Mohammed
HZHadzliana Zainal
Hadzliana Zainal
SOSiew Chin Ong
Siew Chin Ong
Balamurugan TangiisuranBalamurugan Tangiisuran
Balamurugan Tangiisuran
FAFatimatuzzahra’ Abd Aziz
Fatimatuzzahra’ Abd Aziz
ZAZariah A. Aziz
Zariah A. Aziz
Background and Aims: There is a lack of population‐based studies focusing on guideline‐based prognostic models for stroke. This study aimed to develop and validate a prognostic model that predicts mortality following a first‐ever acute ischemic stroke.Methods: The study included 899 adult patients ( ≥ 18 years) with confirmed diagnosis of first‐ever acute ischemic stroke enrolled in the Malaysian National Stroke Registry (NSR) from January 2009 to December 2019. The primary outcome was mortality within 90 days post‐stroke (266 events [29.6%]). The prognostic model was developed using logistic regression (75%, n = 674) and internally validated (25%, n = 225). Model performance was assessed using discrimination (area under the curve (AUC]) and calibration (Hosmer‐Lemeshow test [HL]).Results: The final model includes factors associated with increased risk of mortality, such as age (adjusted odds ratio, aOR 1.06 [95% confidence interval, CI 1.03, 1.10; p < 0.001]), National Institutes of Health Stroke Scale (NIHSS) score aOR 1.08 (95% CI 1.08, 1.13; p = 0.004), and diabetes aOR 2.29 (95% CI 1.20, 4.37; p = 0.012). The protective factors were antiplatelet within 48 h. aOR 0.40 (95% CI 0.19, 0.81; p = 0.01), dysphagia screening aOR 0.30 (95% CI 0.15, 0.61; p = 0.001), antiplatelets upon discharge aOR 0.17 (95% CI 0.08, 0.35; p < 0.001), lipid‐lowering therapy aOR 0.37 (95% CI 0.17, 0.82; p = 0.01), stroke education aOR 0.02 (95% CI 0.01, 0.05; p < 0.001) and rehabilitation aOR 0.08 (95% CI 0.04, 0.16; p < 0.001). The model demonstrated excellent performance (discrimination [AUC = 0.94] and calibration [HL, X2 p = 0.63]).Conclusion: The study developed a validated prognostic model that excellently predicts mortality after a first‐ever acute ischemic stroke with potential clinical utility in acute stroke care decision‐making. The predictors could be valuable for creating risk calculators and aiding healthcare providers and patients in making well‐informed clinical decisions during the stroke care process.

23 December 2021 in ASM Science Journal
Verified
Journal Article
Open access
Mustapha MohammedMustapha Mohammed
Mustapha Mohammed
HZHadzliana Zainal
Hadzliana Zainal
SOSiew Chin Ong
Siew Chin Ong
FAFatimatuzzahra’ Abd Aziz
Fatimatuzzahra’ Abd Aziz
Abubakar Sha'abanAbubakar Sha'aban
Abubakar Sha'aban
Balamurugan TangiisuranBalamurugan Tangiisuran
Balamurugan Tangiisuran
Stroke is one of the leading causes of death and disability globally. Clinical models have been reported to predict stroke outcomes and thus, potentially guide clinical decisions. This study aimed to describe the global trends of research in clinical prediction models of stroke outcomes. A bibliometric analysis was conducted on clinical prediction models of stroke outcomes publications reported in Scopus from 2010 to 2019. Bibliographic data were extracted, quantitatively analysed, and visualized using VOSviewer software. A total of 6,364 publications were included in the final analysis. The number of published studies had steadily increased since 2010. “Stroke” and “Journal of Stroke and Cerebrovascular Diseases” were the journal with the most publications and citations. The most cited publications were by Lip et al. (2010) and Berkhemer et al. (2015). The United States of America (USA), China together with their institutions contributed most to the pool of publications in the field. Our study showed a steady increasing research activity in the clinical prediction of stroke outcomes since 2010, with saturation in recent years. The top articles were published in high-quality stroke-related journals and by high-income countries. There is a need to reinforce research capacities in the field by developing collaborative networks.